{"id":8584,"date":"2025-08-19T14:56:00","date_gmt":"2025-08-19T06:56:00","guid":{"rendered":"https:\/\/regask.com\/?page_id=8584"},"modified":"2025-09-04T17:05:39","modified_gmt":"2025-09-04T09:05:39","slug":"farmaceutica-japon-2025","status":"publish","type":"page","link":"https:\/\/regask.com\/es\/pharma-japan-2025\/","title":{"rendered":"Farmacia Jap\u00f3n 2025"},"content":{"rendered":"<section class=\"section\" id=\"section_1442979714\">\n\t\t<div class=\"section-bg fill\" >\n\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"1\" height=\"1\" src=\"https:\/\/regask.com\/wp-content\/uploads\/2024\/06\/Careers-header-bg.svg\" class=\"bg attachment-medium_large size-medium_large\" alt=\"Encabezado de Carreras Bg\" \/>\t\t\t\t\t\t\n\t\t\t\n\n\t\t<\/div>\n\n\t\t\n\n\t\t<div class=\"section-content relative\">\n\t\t\t\n<div class=\"row row-large align-middle align-center\"  id=\"row-2090560755\">\n\n\t<div id=\"col-545379191\" class=\"col medium-5 small-12 large-5\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n\t<div class=\"img has-hover no-margin x md-x lg-x y md-y lg-y\" id=\"image_604193445\">\n\t\t\t\t\t\t\t\t<div class=\"img-inner dark\" >\n\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"720\" height=\"720\" src=\"https:\/\/regask.com\/wp-content\/uploads\/2025\/08\/RegASK-Pharma-Japan-2025_Landing-Page.png\" class=\"attachment-medium_large size-medium_large\" alt=\"P\u00e1gina de inicio de Regask Pharma Jap\u00f3n 2025\" srcset=\"https:\/\/regask.com\/wp-content\/uploads\/2025\/08\/RegASK-Pharma-Japan-2025_Landing-Page.png 720w, https:\/\/regask.com\/wp-content\/uploads\/2025\/08\/RegASK-Pharma-Japan-2025_Landing-Page-330x330.png 330w, https:\/\/regask.com\/wp-content\/uploads\/2025\/08\/RegASK-Pharma-Japan-2025_Landing-Page-12x12.png 12w\" sizes=\"auto, (max-width: 720px) 100vw, 720px\" \/>\t\t\t\t\t\t\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\n<style>\n#image_604193445 {\n  width: 90%;\n}\n<\/style>\n\t<\/div>\n\t\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-545379191 > .col-inner {\n  border-radius: 30px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-1231114819\" class=\"col medium-6 small-12 large-6\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h5><span style=\"font-size: 95%;\" data-text-color=\"secondary\">REGASK SE UNE<\/span><\/h5>\n<h1 class=\"mt-&#091;1rem&#093; md:mt-&#091;1.5rem&#093; t-h1 text-white\">Farmacia Jap\u00f3n 2025<\/h1>\n<div class=\"is-divider divider clearfix\" style=\"max-width:40px;background-color:rgb(145, 138, 215);\"><\/div>\n\t<div id=\"text-875309005\" class=\"text\">\n\t\t\n<p data-line-height=\"s\"><span data-text-color=\"primary\"><strong>9-10 DE SEPTIEMBRE DE 2025 | JAP\u00d3N<\/strong><\/span><\/p>\n<p data-line-height=\"s\"><span data-text-color=\"primary\"><strong>El Westin, Tokio<\/strong><\/span><\/p>\n\t\t\n<style>\n#text-875309005 {\n  text-align: left;\n  color: rgb(227, 227, 227);\n}\n#text-875309005 > * {\n  color: rgb(227, 227, 227);\n}\n<\/style>\n\t<\/div>\n\t\n<a href=\"https:\/\/regask.com\/es\/reunion-anual-de-dia-singapur-2025\/#register20\" class=\"button secondary hide-for-small\" >\n\t\t<span>Vis\u00edtenos en Pharma Japan 2025<\/span>\n\t<\/a>\n\n<a href=\"https:\/\/regask.com\/es\/reunion-anual-de-dia-singapur-2025\/#register20\" class=\"button secondary show-for-small\" >\n\t\t<span>Vis\u00edtenos en DIA Singapur 2025<\/span>\n\t<\/a>\n\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n\n<style>\n#row-2090560755 > .col > .col-inner {\n  padding: 30px 0px 0px 0px;\n}\n<\/style>\n<\/div>\n\t\t<\/div>\n\n\t\t\n<style>\n#section_1442979714 {\n  padding-top: 30px;\n  padding-bottom: 30px;\n}\n@media (min-width:550px) {\n  #section_1442979714 {\n    padding-top: 30px;\n    padding-bottom: 30px;\n  }\n}\n<\/style>\n\t<\/section>\n\t\n\n<span class=\"scroll-to\" data-label=\"Scroll to: #register20\" data-bullet=\"false\" data-link=\"#register20\" data-title=\"Register\"><a name=\"register20\"><\/a><\/span>\n<div class=\"row row-collapse row-full-width\"  id=\"row-481674964\">\n\n\t<div id=\"col-1364415856\" class=\"col medium-12 small-12 large-6\"  >\n\t\t\t\t<div class=\"col-inner text-center\"  >\n\t\t\t\n\t\t\t\n\n\t<section class=\"section dark\" id=\"section_613510879\">\n\t\t<div class=\"section-bg fill\" >\n\t\t\t\t\t\t\t\t\t\n\t\t\t\n\n\t\t<\/div>\n\n\t\t\n\n\t\t<div class=\"section-content relative\">\n\t\t\t\n<div class=\"row align-center\"  id=\"row-990783458\">\n\n\t<div id=\"col-787315858\" class=\"col medium-9 small-12 large-9\"  >\n\t\t\t\t<div class=\"col-inner text-center\"  >\n\t\t\t\n\t\t\t\n\t<div id=\"text-1469221969\" class=\"text\">\n\t\t\n<h3>Conozca a nuestro equipo en Pharma Japan 2025<\/h3>\n\t\t\n<style>\n#text-1469221969 {\n  font-size: 1.5rem;\n  text-align: left;\n}\n<\/style>\n\t<\/div>\n\t\n\t<div id=\"gap-1384614514\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1384614514 {\n  padding-top: 30px;\n}\n<\/style>\n\t<\/div>\n\t\n\t<div id=\"text-604425388\" class=\"text\">\n\t\t\n<p data-start=\"100\" data-end=\"441\">Unirse <strong data-start=\"105\" data-end=\"141\">Caroline Shleifer, fundadora y directora ejecutiva<\/strong>, y <strong data-start=\"147\" data-end=\"194\">Oliver Stein, Director de Desarrollo Comercial<\/strong>, ya que representan RegASK en <strong data-start=\"224\" data-end=\"245\">Farmacia Jap\u00f3n 2025<\/strong>Caroline subir\u00e1 al escenario con una sesi\u00f3n magistral sobre <em data-start=\"302\" data-end=\"369\">Inteligencia artificial agente x inteligencia regulatoria: de una carga a un gran avance<\/em>, compartiendo c\u00f3mo los agentes de IA inteligentes est\u00e1n redefiniendo los asuntos regulatorios.<\/p>\n<p data-start=\"443\" data-end=\"616\">Esta es una gran oportunidad para conectarse, explorar la inteligencia regulatoria impulsada por IA y ver c\u00f3mo RegASK potencia un cumplimiento m\u00e1s inteligente y r\u00e1pido en los mercados din\u00e1micos de las ciencias biol\u00f3gicas.<\/p>\n\t\t\n<style>\n#text-604425388 {\n  text-align: left;\n}\n<\/style>\n\t<\/div>\n\t\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-787315858 > .col-inner {\n  margin: 0px 40px 0px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n<\/div>\n<div class=\"row align-center\"  id=\"row-1694053709\">\n\n\t<div id=\"col-2008036540\" class=\"col medium-9 small-12 large-9\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n\t<div class=\"box has-hover   has-hover box-default box-text-bottom\" >\n\n\t\t<div class=\"box-image\" >\n\t\t\t\t\t\t<div class=\"\" >\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"979\" height=\"401\" src=\"https:\/\/regask.com\/wp-content\/uploads\/2025\/09\/Pharma-Japan-2025-attendees-5.png\" class=\"attachment- size-\" alt=\"5 asistentes a Pharma Japan 2025\" srcset=\"https:\/\/regask.com\/wp-content\/uploads\/2025\/09\/Pharma-Japan-2025-attendees-5.png 979w, https:\/\/regask.com\/wp-content\/uploads\/2025\/09\/Pharma-Japan-2025-attendees-5-330x135.png 330w, https:\/\/regask.com\/wp-content\/uploads\/2025\/09\/Pharma-Japan-2025-attendees-5-18x7.png 18w\" sizes=\"auto, (max-width: 979px) 100vw, 979px\" \/>\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\t<div class=\"box-text text-center is-small\" >\n\t\t\t<div class=\"box-text-inner\">\n\t\t\t\t\n\t<div id=\"gap-1806576717\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1806576717 {\n  padding-top: 20px;\n}\n<\/style>\n\t<\/div>\n\t\n<div class=\"row align-center\"  id=\"row-1322453682\">\n\n\t<div id=\"col-435563406\" class=\"col medium-6 small-12 large-6\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<p><span style=\"font-size: 100%;\"><strong>Oliver Stein<\/strong><\/span><\/p>\n<p>Director de Desarrollo de Negocios<\/p>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n\n\t<div id=\"col-571780351\" class=\"col medium-6 small-12 large-6\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<p><span style=\"font-size: 100%;\"><strong>Carolina Shleifer<\/strong><\/span><\/p>\n<p>Fundador y director ejecutivo<\/p>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t<\/div>\n\t\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n\n<\/div>\n\t\t<\/div>\n\n\t\t\n<style>\n#section_613510879 {\n  padding-top: 70px;\n  padding-bottom: 70px;\n  min-height: 800px;\n  background-color: rgb(10, 35, 66);\n}\n@media (min-width:550px) {\n  #section_613510879 {\n    padding-top: 30px;\n    padding-bottom: 30px;\n  }\n}\n<\/style>\n\t<\/section>\n\t\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n\n\t<div id=\"col-719827885\" class=\"col medium-12 small-12 large-6\"  >\n\t\t\t\t<div class=\"col-inner text-center\"  >\n\t\t\t\n\t\t\t\n\n\t<section class=\"section dark\" id=\"section_1985366505\">\n\t\t<div class=\"section-bg fill\" >\n\t\t\t\t\t\t\t\t\t\n\t\t\t\n\n\t\t<\/div>\n\n\t\t\n\n\t\t<div class=\"section-content relative\">\n\t\t\t\n<div class=\"row align-center\"  id=\"row-1652181643\">\n\n\t<div id=\"col-2025332461\" class=\"col medium-10 small-12 large-10\"  data-animate=\"fadeInRight\">\n\t\t\t\t<div class=\"col-inner text-center box-shadow-2\" style=\"background-color:rgb(255, 255, 255);\" >\n\t\t\t\n\t\t\t\n\n<p><script charset=\"utf-8\" type=\"text\/javascript\" src=\"\/\/js.hsforms.net\/forms\/embed\/v2.js\"><\/script><br \/>\n<script>\n  hbspt.forms.create({\n    portalId: \"20908020\",\n    formId: \"c5958a92-9a17-41d3-a4e6-c5032e3156ff\",\n    region: \"na1\"\n  });\n<\/script><br \/>\n\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-2025332461 > .col-inner {\n  padding: 30px 30px 30px 30px;\n  border-radius: 16px;\n}\n<\/style>\n\t<\/div>\n\n\t\n<\/div>\n\t\t<\/div>\n\n\t\t\n<style>\n#section_1985366505 {\n  padding-top: 70px;\n  padding-bottom: 70px;\n  min-height: 800px;\n  background-color: rgb(251, 250, 254);\n}\n@media (min-width:550px) {\n  #section_1985366505 {\n    padding-top: 0px;\n    padding-bottom: 0px;\n  }\n}\n<\/style>\n\t<\/section>\n\t\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n<\/div>\n\n\t<section class=\"section\" id=\"section_991182035\">\n\t\t<div class=\"section-bg fill\" >\n\t\t\t<img decoding=\"async\" src=\"https:\/\/regask.com\/wp-content\/uploads\/2024\/07\/bg-flip-card-1.svg\" class=\"bg attachment- size-\" alt=\"Tarjeta de visita 1 de Bg\" \/>\t\t\t\t\t\t\n\t\t\t\n\n\t\t<\/div>\n\n\t\t\n\n\t\t<div class=\"section-content relative\">\n\t\t\t\n<div class=\"row\"  id=\"row-1012903759\">\n\n\t<div id=\"col-1495929715\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h2 class=\"mt-&#091;1rem&#093; md:mt-&#091;1.5rem&#093; t-h1 text-white\">Farmacia Jap\u00f3n 2025<\/h2>\n\t<div id=\"text-494070982\" class=\"text\">\n\t\t\n<p><strong data-start=\"597\" data-end=\"634\">Eventos de Reuters: Pharma Japan 2025<\/strong> es <strong data-start=\"638\" data-end=\"694\">La conferencia ejecutiva farmac\u00e9utica m\u00e1s grande y \u00fanica de Jap\u00f3n<\/strong>, reuniendo a los principales l\u00edderes de los sectores comercial, de ventas, de marketing, m\u00e9dico, de participaci\u00f3n del paciente, RWE, cl\u00ednico, de acceso al mercado, digital, TI y m\u00e1s para dar forma al futuro de la innovaci\u00f3n farmac\u00e9utica japonesa.<\/p>\n<h3><span style=\"font-size: 85%;\">Los temas clave incluyen:<\/span><\/h3>\n<ul>\n<li data-start=\"966\" data-end=\"1027\">El cambio urgente hacia una <strong data-start=\"992\" data-end=\"1027\">modelo de negocio centrado en el cliente<\/strong><\/li>\n<li data-start=\"966\" data-end=\"1027\">Integraci\u00f3n de <strong data-start=\"1045\" data-end=\"1104\">comercial, marketing, I+D, cl\u00ednico, datos y digital<\/strong> Funciones con la experiencia del paciente en el centro<\/li>\n<li data-start=\"966\" data-end=\"1027\"><strong data-start=\"1193\" data-end=\"1210\">Innovaci\u00f3n en IA<\/strong> Para personalizar la participaci\u00f3n y optimizar los recursos, destacando la programaci\u00f3n interactiva y pr\u00e1ctica, como debates, hackatones y debates piloto en el mundo real.<\/li>\n<\/ul>\n<h3><span style=\"font-size: 85%;\">Lugar y horario:<\/span><\/h3>\n<p data-start=\"1434\" data-end=\"1515\">\ud83d\udccd The Westin Tokyo, 1 Chome-4-1 Mita, ciudad de Meguro, Tokio 153-8580, Jap\u00f3n<br data-start=\"151\" data-end=\"154\" \/>\ud83d\uddd3 9 y 10 de septiembre de 2025 | 9:00 a. m. a 5:00 p. m. (GMT+9)<\/p>\n\t\t\n<style>\n#text-494070982 {\n  text-align: left;\n  color: rgb(17, 59, 111);\n}\n#text-494070982 > * {\n  color: rgb(17, 59, 111);\n}\n<\/style>\n\t<\/div>\n\t\n\t<div id=\"gap-361119970\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-361119970 {\n  padding-top: 20px;\n}\n<\/style>\n\t<\/div>\n\t\n<h3 class=\"mt-&#091;1rem&#093; md:mt-&#091;1.5rem&#093; t-h1 text-white\">Lo que RegASK aporta a la industria farmac\u00e9utica<\/h3>\n\t<div id=\"gap-143298128\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-143298128 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n\t<div id=\"text-77616955\" class=\"text\">\n\t\t\n<p data-start=\"241\" data-end=\"389\">En RegASK apoyamos a las empresas farmac\u00e9uticas con <strong data-start=\"293\" data-end=\"330\">Inteligencia regulatoria impulsada por IA<\/strong> para ayudarles a mantenerse a la vanguardia en un panorama en r\u00e1pida evoluci\u00f3n.<\/p>\n<p data-start=\"391\" data-end=\"437\"><strong data-start=\"391\" data-end=\"435\">As\u00ed es como agregamos valor a la industria:<\/strong><\/p>\n<ul data-start=\"438\" data-end=\"951\">\n<li data-start=\"438\" data-end=\"528\">\n<p data-start=\"440\" data-end=\"528\"><strong data-start=\"440\" data-end=\"480\">Navegar por las complejas regulaciones de Jap\u00f3n<\/strong> con seguimiento y perspectivas de expertos<\/p>\n<\/li>\n<li data-start=\"529\" data-end=\"626\">\n<p data-start=\"531\" data-end=\"626\"><strong data-start=\"531\" data-end=\"566\">Acelerar los flujos de trabajo de cumplimiento<\/strong> a trav\u00e9s de la automatizaci\u00f3n habilitada por IA y la inteligencia predictiva<\/p>\n<\/li>\n<li data-start=\"627\" data-end=\"726\">\n<p data-start=\"629\" data-end=\"726\"><strong data-start=\"629\" data-end=\"665\">Garantizar la alineaci\u00f3n global y local<\/strong> para estrategias regulatorias farmac\u00e9uticas en APAC y en todo el mundo<\/p>\n<\/li>\n<li data-start=\"727\" data-end=\"822\">\n<p data-start=\"729\" data-end=\"822\"><strong data-start=\"729\" data-end=\"767\">Reducir el riesgo y optimizar los recursos<\/strong> con alertas proactivas y recomendaciones pr\u00e1cticas<\/p>\n<\/li>\n<li data-start=\"823\" data-end=\"951\">\n<p data-start=\"825\" data-end=\"951\"><strong data-start=\"825\" data-end=\"847\">Potenciar la innovaci\u00f3n<\/strong> Al liberar a los equipos para que se concentren en iniciativas centradas en el paciente mientras RegASK gestiona las complejidades del cumplimiento<\/p>\n<\/li>\n<\/ul>\n<p data-start=\"953\" data-end=\"1100\">Al combinar la experiencia regulatoria con inteligencia artificial avanzada, RegASK permite a las compa\u00f1\u00edas farmac\u00e9uticas ofrecer innovaci\u00f3n con confianza, velocidad y cumplimiento.<\/p>\n\t\t\n<style>\n#text-77616955 {\n  text-align: left;\n  color: rgb(17, 59, 111);\n}\n#text-77616955 > * {\n  color: rgb(17, 59, 111);\n}\n<\/style>\n\t<\/div>\n\t\n\t<div id=\"gap-1031939941\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1031939941 {\n  padding-top: 20px;\n}\n<\/style>\n\t<\/div>\n\t\n<a href=\"https:\/\/regask.com\/es\/reunion-anual-de-dia-singapur-2025\/#register20\" class=\"button secondary hide-for-small\" >\n\t\t<span>\u00a1Nos vemos en Pharma Japan 2025!<\/span>\n\t<\/a>\n\n<a href=\"https:\/\/regask.com\/es\/reunion-anual-de-dia-singapur-2025\/#register20\" class=\"button secondary show-for-small\" >\n\t\t<span>\u00a1Nos vemos en DIA Singapur 2025!<\/span>\n\t<\/a>\n\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n<\/div>\n\t\t<\/div>\n\n\t\t\n<style>\n#section_991182035 {\n  padding-top: 60px;\n  padding-bottom: 60px;\n  background-color: rgb(255, 255, 255);\n}\n<\/style>\n\t<\/section>\n\t\n\n\t<section class=\"section\" id=\"section_203174725\">\n\t\t<div class=\"section-bg fill\" >\n\t\t\t\t\t\t\t\t\t\n\t\t\t\n\n\t\t<\/div>\n\n\t\t\n\n\t\t<div class=\"section-content relative\">\n\t\t\t\n<div class=\"row align-equal align-center\"  id=\"row-14293908\">\n\n\t<div id=\"col-1620532754\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h2>Nuestra soluci\u00f3n<\/h2>\n<p>RegASK aprovecha la inteligencia artificial avanzada y el aprendizaje autom\u00e1tico para ayudar a las empresas de sectores altamente regulados a optimizar sus procesos de cumplimiento normativo y mantenerse a la vanguardia. Nuestra soluci\u00f3n de vanguardia automatiza la investigaci\u00f3n regulatoria, brinda informaci\u00f3n vital y permite que los equipos de asuntos regulatorios se conviertan en socios estrat\u00e9gicos para impulsar el crecimiento empresarial.<\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1620532754 > .col-inner {\n  padding: 0px 0px 0px 0px;\n}\n@media (min-width:550px) {\n  #col-1620532754 > .col-inner {\n    padding: 0px 50px 0px 50px;\n  }\n}\n@media (min-width:850px) {\n  #col-1620532754 > .col-inner {\n    padding: 0px 170px 0px 0px;\n  }\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-1873841086\" class=\"col medium-5 small-12 large-3\"  data-animate=\"bounceIn\">\n\t\t\t\t<div class=\"col-inner\" style=\"background-color:rgb(255,255,255);\" >\n\t\t\t\n\t<div class=\"is-border\"\n\t\tstyle=\"border-color:rgb(229, 232, 251);border-radius:30px;border-width:2px 2px 2px 2px;\">\n\t<\/div>\n\t\t\t\n\n\t\t<div class=\"icon-box featured-box icon-box-top text-left\"  >\n\t\t\t\t\t<div class=\"icon-box-img\" style=\"width: 64px\">\n\t\t\t\t<div class=\"icon\">\n\t\t\t\t\t<div class=\"icon-inner\" >\n\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"1\" height=\"1\" src=\"https:\/\/regask.com\/wp-content\/uploads\/2024\/07\/RegGenius-Product-Icon-2.svg\" class=\"attachment-medium size-medium\" alt=\"Icono de producto Reggenius (2)\" \/>\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\t\t<div class=\"icon-box-text last-reset\">\n\t\t\t\t\t\t\t\t\t\n\t<div id=\"text-1412785367\" class=\"text\">\n\t\t\n<h4 style=\"margin: 10px 0;\">RegGenius<\/h4>\n\t\t\n<style>\n#text-1412785367 {\n  color: rgb(10, 35, 66);\n}\n#text-1412785367 > * {\n  color: rgb(10, 35, 66);\n}\n<\/style>\n\t<\/div>\n\t\n\t<div id=\"text-1477139488\" class=\"text\">\n\t\t\n<p>Aproveche el poder de la IA para obtener una ventaja competitiva en el cumplimiento normativo.<br \/>\n\t\t\n<style>\n#text-1477139488 {\n  font-size: 0.87rem;\n  color: rgb(17, 59, 111);\n}\n#text-1477139488 > * {\n  color: rgb(17, 59, 111);\n}\n<\/style>\n\t<\/div>\n\t\n\t\t<\/div>\n\t<\/div>\n\t\n\t\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1873841086 > .col-inner {\n  padding: 30px 20px 30px 20px;\n  margin: 0px 0px 0px 0px;\n  border-radius: 30px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-1527379695\" class=\"col medium-5 small-12 large-3\"  data-animate=\"bounceIn\">\n\t\t\t\t<div class=\"col-inner\" style=\"background-color:rgb(255,255,255);\" >\n\t\t\t\n\t<div class=\"is-border\"\n\t\tstyle=\"border-color:rgb(229, 232, 251);border-radius:30px;border-width:2px 2px 2px 2px;\">\n\t<\/div>\n\t\t\t\n\n\t\t<div class=\"icon-box featured-box icon-box-top text-left\"  >\n\t\t\t\t\t<div class=\"icon-box-img\" style=\"width: 64px\">\n\t\t\t\t<div class=\"icon\">\n\t\t\t\t\t<div class=\"icon-inner\" >\n\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"1\" height=\"1\" src=\"https:\/\/regask.com\/wp-content\/uploads\/2024\/07\/Alerts-icon.svg\" class=\"attachment-medium size-medium\" alt=\"Icono de alertas\" \/>\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\t\t<div class=\"icon-box-text last-reset\">\n\t\t\t\t\t\t\t\t\t\n\t<div id=\"text-363866849\" class=\"text\">\n\t\t\n<h4 style=\"margin: 10px 0;\">Alerta de registro<\/h4>\n\t\t\n<style>\n#text-363866849 {\n  color: rgb(10, 35, 66);\n}\n#text-363866849 > * {\n  color: rgb(10, 35, 66);\n}\n<\/style>\n\t<\/div>\n\t\n\t<div id=\"text-2894756520\" class=\"text\">\n\t\t\n<p>Sin sorpresas con el monitoreo regulatorio automatizado.<br \/>\n\t\t\n<style>\n#text-2894756520 {\n  font-size: 0.87rem;\n  color: rgb(17, 59, 111);\n}\n#text-2894756520 > * {\n  color: rgb(17, 59, 111);\n}\n<\/style>\n\t<\/div>\n\t\n\t\t<\/div>\n\t<\/div>\n\t\n\t\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1527379695 > .col-inner {\n  padding: 30px 20px 30px 20px;\n  margin: 0px 0px 0px 0px;\n  border-radius: 30px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-1582383035\" class=\"col medium-5 small-12 large-3\"  data-animate=\"bounceIn\">\n\t\t\t\t<div class=\"col-inner\" style=\"background-color:rgb(255,255,255);\" >\n\t\t\t\n\t<div class=\"is-border\"\n\t\tstyle=\"border-color:rgb(229, 232, 251);border-radius:30px;border-width:2px 2px 2px 2px;\">\n\t<\/div>\n\t\t\t\n\n\t\t<div class=\"icon-box featured-box icon-box-top text-left\"  >\n\t\t\t\t\t<div class=\"icon-box-img\" style=\"width: 64px\">\n\t\t\t\t<div class=\"icon\">\n\t\t\t\t\t<div class=\"icon-inner\" >\n\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"1\" height=\"1\" src=\"https:\/\/regask.com\/wp-content\/uploads\/2024\/07\/Data-Driven-Excellence-icon.svg\" class=\"attachment-medium size-medium\" alt=\"Icono de excelencia basada en datos\" \/>\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\t\t<div class=\"icon-box-text last-reset\">\n\t\t\t\t\t\t\t\t\t\n\t<div id=\"text-2359934311\" class=\"text\">\n\t\t\n<h4 style=\"margin: 10px 0;\">RegInsights<\/h4>\n\t\t\n<style>\n#text-2359934311 {\n  color: rgb(10, 35, 66);\n}\n#text-2359934311 > * {\n  color: rgb(10, 35, 66);\n}\n<\/style>\n\t<\/div>\n\t\n\t<div id=\"text-2657335452\" class=\"text\">\n\t\t\n<p>Identifique tendencias, anticipe riesgos y construya mejores estrategias.<br \/>\n\t\t\n<style>\n#text-2657335452 {\n  font-size: 0.87rem;\n  color: rgb(17, 59, 111);\n}\n#text-2657335452 > * {\n  color: rgb(17, 59, 111);\n}\n<\/style>\n\t<\/div>\n\t\n\t\t<\/div>\n\t<\/div>\n\t\n\t\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1582383035 > .col-inner {\n  padding: 30px 20px 30px 20px;\n  margin: 0px 0px 0px 0px;\n  border-radius: 30px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-308849390\" class=\"col medium-5 small-12 large-3\"  data-animate=\"bounceIn\">\n\t\t\t\t<div class=\"col-inner\" style=\"background-color:rgb(255,255,255);\" >\n\t\t\t\n\t<div class=\"is-border\"\n\t\tstyle=\"border-color:rgb(229, 232, 251);border-radius:30px;border-width:2px 2px 2px 2px;\">\n\t<\/div>\n\t\t\t\n\n\t\t<div class=\"icon-box featured-box icon-box-top text-left\"  >\n\t\t\t\t\t<div class=\"icon-box-img\" style=\"width: 64px\">\n\t\t\t\t<div class=\"icon\">\n\t\t\t\t\t<div class=\"icon-inner\" >\n\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"1\" height=\"1\" src=\"https:\/\/regask.com\/wp-content\/uploads\/2024\/07\/AskRegASK-Product-Icon.svg\" class=\"attachment-medium size-medium\" alt=\"Icono del producto AskRegASK\" \/>\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\t\t<div class=\"icon-box-text last-reset\">\n\t\t\t\t\t\t\t\t\t\n\t<div id=\"text-2894702842\" class=\"text\">\n\t\t\n<h4 style=\"margin: 10px 0;\">Ask RegASK<\/h4>\n\t\t\n<style>\n#text-2894702842 {\n  color: rgb(10, 35, 66);\n}\n#text-2894702842 > * {\n  color: rgb(10, 35, 66);\n}\n<\/style>\n\t<\/div>\n\t\n\t<div id=\"text-3316230368\" class=\"text\">\n\t\t\n<p>Acceso a nuestra comunidad de expertos en temas regulatorios.<br \/>\n\t\t\n<style>\n#text-3316230368 {\n  font-size: 0.87rem;\n  color: rgb(17, 59, 111);\n}\n#text-3316230368 > * {\n  color: rgb(17, 59, 111);\n}\n<\/style>\n\t<\/div>\n\t\n\t\t<\/div>\n\t<\/div>\n\t\n\t\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-308849390 > .col-inner {\n  padding: 30px 20px 30px 20px;\n  margin: 0px 0px 30px 0px;\n  border-radius: 30px;\n}\n@media (min-width:550px) {\n  #col-308849390 > .col-inner {\n    margin: 0px 0px 0px 0px;\n  }\n}\n<\/style>\n\t<\/div>\n\n\t\n<\/div>\n\t\t<\/div>\n\n\t\t\n<style>\n#section_203174725 {\n  padding-top: 0px;\n  padding-bottom: 0px;\n  background-color: rgb(250, 250, 250);\n}\n@media (min-width:550px) {\n  #section_203174725 {\n    padding-top: 60px;\n    padding-bottom: 60px;\n  }\n}\n<\/style>\n\t<\/section>\n\t\n\n\t<section class=\"section\" id=\"section_71050757\">\n\t\t<div class=\"section-bg fill\" >\n\t\t\t\t\t\t\t\t\t\n\t\t\t\n\n\t\t<\/div>\n\n\t\t\n\n\t\t<div class=\"section-content relative\">\n\t\t\t\n<div class=\"row align-center\"  id=\"row-30095505\">\n\n\t<div id=\"col-1617262496\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner text-center\"  >\n\t\t\t\n\t\t\t\n<h2>Recursos<\/h2>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1617262496 > .col-inner {\n  padding: 50px 0px 0px 0px;\n  margin: 30px 0px 0px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-1418442477\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n\n  \n    <div class=\"row eneko-case-studies radius-30 large-columns-3 medium-columns-2 small-columns-1 slider row-slider slider-nav-simple slider-nav-outside slider-nav-push\"  data-flickity-options='{&quot;imagesLoaded&quot;: true, &quot;groupCells&quot;: &quot;100%&quot;, &quot;dragThreshold&quot; : 5, &quot;cellAlign&quot;: &quot;left&quot;,&quot;wrapAround&quot;: true,&quot;prevNextButtons&quot;: true,&quot;percentPosition&quot;: true,&quot;pageDots&quot;: true, &quot;rightToLeft&quot;: false, &quot;autoPlay&quot; : false}' >\n\n  <div class=\"col post-item\" >\n\t\t\t<div class=\"col-inner\">\n\t\t\t\t<div class=\"box box-normal box-text-bottom box-blog-post has-hover\">\n            \t\t\t\t\t<div class=\"box-image\" >\n  \t\t\t\t\t\t<div class=\"image-cover\" style=\"padding-top:56%;\">\n\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/es\/us-government-shutdown-life-sciences-impact\/\" class=\"plain\" aria-label=\"Gestionando un posible cierre del gobierno de EE. UU.: Implica\u2026\">\n\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"576\" src=\"https:\/\/regask.com\/wp-content\/uploads\/2025\/03\/navigating-potential-us-government-shutdown-implications-life-sciences-sector.jpg\" class=\"attachment-medium_large size-medium_large wp-post-image\" alt=\"An\u00e1lisis de las posibles implicaciones del cierre del gobierno estadounidense para el sector de las ciencias biol\u00f3gicas\" srcset=\"https:\/\/regask.com\/wp-content\/uploads\/2025\/03\/navigating-potential-us-government-shutdown-implications-life-sciences-sector.jpg 800w, https:\/\/regask.com\/wp-content\/uploads\/2025\/03\/navigating-potential-us-government-shutdown-implications-life-sciences-sector-330x248.jpg 330w, https:\/\/regask.com\/wp-content\/uploads\/2025\/03\/navigating-potential-us-government-shutdown-implications-life-sciences-sector-16x12.jpg 16w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" \/>\t\t\t\t\t\t\t<\/a>\n  \t\t\t\t\t\t\t  \t\t\t\t\t\t\t  \t\t\t\t\t\t<\/div>\n  \t\t\t\t\t\t  \t\t\t\t\t<\/div>\n          \t\t\t\t\t<div class=\"box-text text-left\" style=\"padding:20px 0px 0px 0px;\">\n\t\t\t\t\t<div class=\"box-text-inner blog-post-inner\">\n\n\t\t\t\t\t\n\t\t\t\t\t<div class=\"post-meta is-small op-8\">11 de marzo de 2025 -  <a style=\"color:#453AAB!important;\" href=\"https:\/\/regask.com\/es\/category\/blogs\/\">Blogs<\/a><\/div>\t\t\t\t\t\n\n\t\t\t\t\t<div class=\"is-divider\"><\/div>\n\n\t\t\t\t\t<h5 class=\"post-title is-large\">\n\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/es\/us-government-shutdown-life-sciences-impact\/\" class=\"plain\">Gestionando un posible cierre del gobierno de EE. UU.: Implica\u2026<\/a>\n\t\t\t\t\t<\/h5>\n\t\t\t\t\t\n\t\t\t\t\t<div class=\"min-height-excerpt\">\n\t\t\t\t\tMientras los legisladores en Washington, DC, enfrentan una fecha l\u00edmite cr\u00edtica del 14 de marzo para finalizar el gasto federal, la posibilidad de un cambio de gobierno en EE.UU.\u2026 <br \/>\t\t\t\t\t<\/div>\n\n\t\t\t\t\t\n\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/es\/us-government-shutdown-life-sciences-impact\/\" class=\"button  is-link is-small mb-0\">\n\t\t\t\t\t\t\tLeer m\u00e1s\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"eneko_tags_cat\"><h6 class=\"entry-category is-xsmall\"><a href=\"https:\/\/regask.com\/es\/category\/blogs\/\" class=\"category-blogs\">Blogs<\/a> <a href=\"https:\/\/regask.com\/es\/category\/region\/north-america\/united-states-regulations\/\" class=\"category-united-states-regulations\">Estados Unidos<\/a> <a href=\"https:\/\/regask.com\/es\/category\/blogs\/pharma-and-biotech-news\/\" class=\"category-pharma-and-biotech-news\">Farmacia y biotecnolog\u00eda<\/a><\/h6><\/div>\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div><div class=\"col post-item\" >\n\t\t\t<div class=\"col-inner\">\n\t\t\t\t<div class=\"box box-normal box-text-bottom box-blog-post has-hover\">\n            \t\t\t\t\t<div class=\"box-image\" >\n  \t\t\t\t\t\t<div class=\"image-cover\" style=\"padding-top:56%;\">\n\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/es\/2024-gartner-feature\/\" class=\"plain\" aria-label=\"RegASK aparece en la Gu\u00eda de mercado de Gartner para la regulaci\u00f3n\u2026\">\n\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"576\" src=\"https:\/\/regask.com\/wp-content\/uploads\/2024\/11\/regask-recognized-market-guide-gartner.jpg\" class=\"attachment-medium_large size-medium_large wp-post-image\" alt=\"Regask, gu\u00eda de mercado reconocida por Gartner\" srcset=\"https:\/\/regask.com\/wp-content\/uploads\/2024\/11\/regask-recognized-market-guide-gartner.jpg 800w, https:\/\/regask.com\/wp-content\/uploads\/2024\/11\/regask-recognized-market-guide-gartner-330x248.jpg 330w, https:\/\/regask.com\/wp-content\/uploads\/2024\/11\/regask-recognized-market-guide-gartner-16x12.jpg 16w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" \/>\t\t\t\t\t\t\t<\/a>\n  \t\t\t\t\t\t\t  \t\t\t\t\t\t\t  \t\t\t\t\t\t<\/div>\n  \t\t\t\t\t\t  \t\t\t\t\t<\/div>\n          \t\t\t\t\t<div class=\"box-text text-left\" style=\"padding:20px 0px 0px 0px;\">\n\t\t\t\t\t<div class=\"box-text-inner blog-post-inner\">\n\n\t\t\t\t\t\n\t\t\t\t\t<div class=\"post-meta is-small op-8\">21 de noviembre de 2024 -  <a style=\"color:#453AAB!important;\" href=\"https:\/\/regask.com\/es\/category\/company-news\/\">Noticias de la empresa<\/a><\/div>\t\t\t\t\t\n\n\t\t\t\t\t<div class=\"is-divider\"><\/div>\n\n\t\t\t\t\t<h5 class=\"post-title is-large\">\n\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/es\/2024-gartner-feature\/\" class=\"plain\">RegASK aparece en la Gu\u00eda de mercado de Gartner para la regulaci\u00f3n\u2026<\/a>\n\t\t\t\t\t<\/h5>\n\t\t\t\t\t\n\t\t\t\t\t<div class=\"min-height-excerpt\">\n\t\t\t\t\t\u00a1Nos complace anunciar que RegASK ha sido incluido en la Gu\u00eda de mercado de Gartner para soluciones de inteligencia regulatoria! Este reconocimiento\u2026 <br \/>\t\t\t\t\t<\/div>\n\n\t\t\t\t\t\n\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/es\/2024-gartner-feature\/\" class=\"button  is-link is-small mb-0\">\n\t\t\t\t\t\t\tLeer m\u00e1s\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"eneko_tags_cat\"><h6 class=\"entry-category is-xsmall\"><a href=\"https:\/\/regask.com\/es\/category\/company-news\/\" class=\"category-company-news\">Noticias de la empresa<\/a><\/h6><\/div>\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div><div class=\"col post-item\" >\n\t\t\t<div class=\"col-inner\">\n\t\t\t\t<div class=\"box box-normal box-text-bottom box-blog-post has-hover\">\n            \t\t\t\t\t<div class=\"box-image\" >\n  \t\t\t\t\t\t<div class=\"image-cover\" style=\"padding-top:56%;\">\n\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/es\/the-2025-state-of-regulatory-affairs-and-compliance-report\/\" class=\"plain\" aria-label=\"Informe sobre el estado de los asuntos regulatorios y el cumplimiento en 2025\">\n\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"576\" src=\"https:\/\/regask.com\/wp-content\/uploads\/2024\/11\/2025-survey-report.png\" class=\"attachment-medium_large size-medium_large wp-post-image\" alt=\"Imagen destacada del sitio web 800 600\" srcset=\"https:\/\/regask.com\/wp-content\/uploads\/2024\/11\/2025-survey-report.png 800w, https:\/\/regask.com\/wp-content\/uploads\/2024\/11\/2025-survey-report-330x248.png 330w, https:\/\/regask.com\/wp-content\/uploads\/2024\/11\/2025-survey-report-16x12.png 16w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" \/>\t\t\t\t\t\t\t<\/a>\n  \t\t\t\t\t\t\t  \t\t\t\t\t\t\t  \t\t\t\t\t\t<\/div>\n  \t\t\t\t\t\t  \t\t\t\t\t<\/div>\n          \t\t\t\t\t<div class=\"box-text text-left\" style=\"padding:20px 0px 0px 0px;\">\n\t\t\t\t\t<div class=\"box-text-inner blog-post-inner\">\n\n\t\t\t\t\t\n\t\t\t\t\t<div class=\"post-meta is-small op-8\">15 de noviembre de 2024 -  <a style=\"color:#453AAB!important;\" href=\"https:\/\/regask.com\/es\/category\/reports\/\">Informes<\/a><\/div>\t\t\t\t\t\n\n\t\t\t\t\t<div class=\"is-divider\"><\/div>\n\n\t\t\t\t\t<h5 class=\"post-title is-large\">\n\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/es\/the-2025-state-of-regulatory-affairs-and-compliance-report\/\" class=\"plain\">Informe sobre el estado de los asuntos regulatorios y el cumplimiento en 2025<\/a>\n\t\t\t\t\t<\/h5>\n\t\t\t\t\t\n\t\t\t\t\t<div class=\"min-height-excerpt\">\n\t\t\t\t\t\u00bfEst\u00e1 su organizaci\u00f3n preparada para las complejidades regulatorias de 2025? El panorama regulatorio en 2025 es m\u00e1s complejo que nunca, con nuevas adv\u2026 <br \/>\t\t\t\t\t<\/div>\n\n\t\t\t\t\t\n\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/es\/the-2025-state-of-regulatory-affairs-and-compliance-report\/\" class=\"button  is-link is-small mb-0\">\n\t\t\t\t\t\t\tLeer m\u00e1s\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"eneko_tags_cat\"><h6 class=\"entry-category is-xsmall\"><a href=\"https:\/\/regask.com\/es\/category\/reports\/\" class=\"category-reports\">Informes<\/a><\/h6><\/div>\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div><div class=\"col post-item\" >\n\t\t\t<div class=\"col-inner\">\n\t\t\t\t<div class=\"box box-normal box-text-bottom box-blog-post has-hover\">\n            \t\t\t\t\t<div class=\"box-image\" >\n  \t\t\t\t\t\t<div class=\"image-cover\" style=\"padding-top:56%;\">\n\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/es\/doge-fda-lease-cancellations\/\" class=\"plain\" aria-label=\"DOGE afirma haber ahorrado $30M al cancelar 30 contratos de arrendamiento de la FDA\">\n\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"576\" src=\"https:\/\/regask.com\/wp-content\/uploads\/2025\/03\/doge-claims-30m-savings-canceling-30-fda-leases.png\" class=\"attachment-medium_large size-medium_large wp-post-image\" alt=\"Doge anuncia un ahorro de 30 millones al cancelar 30 contratos de arrendamiento de la FDA\" srcset=\"https:\/\/regask.com\/wp-content\/uploads\/2025\/03\/doge-claims-30m-savings-canceling-30-fda-leases.png 800w, https:\/\/regask.com\/wp-content\/uploads\/2025\/03\/doge-claims-30m-savings-canceling-30-fda-leases-330x248.png 330w, https:\/\/regask.com\/wp-content\/uploads\/2025\/03\/doge-claims-30m-savings-canceling-30-fda-leases-16x12.png 16w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" \/>\t\t\t\t\t\t\t<\/a>\n  \t\t\t\t\t\t\t  \t\t\t\t\t\t\t  \t\t\t\t\t\t<\/div>\n  \t\t\t\t\t\t  \t\t\t\t\t<\/div>\n          \t\t\t\t\t<div class=\"box-text text-left\" style=\"padding:20px 0px 0px 0px;\">\n\t\t\t\t\t<div class=\"box-text-inner blog-post-inner\">\n\n\t\t\t\t\t\n\t\t\t\t\t<div class=\"post-meta is-small op-8\">7 de marzo de 2025 -  <a style=\"color:#453AAB!important;\" href=\"https:\/\/regask.com\/es\/category\/news\/\">Noticias regulatorias<\/a><\/div>\t\t\t\t\t\n\n\t\t\t\t\t<div class=\"is-divider\"><\/div>\n\n\t\t\t\t\t<h5 class=\"post-title is-large\">\n\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/es\/doge-fda-lease-cancellations\/\" class=\"plain\">DOGE afirma haber ahorrado $30M al cancelar 30 contratos de arrendamiento de la FDA<\/a>\n\t\t\t\t\t<\/h5>\n\t\t\t\t\t\n\t\t\t\t\t<div class=\"min-height-excerpt\">\n\t\t\t\t\t\t\t\t\t\t<\/div>\n\n\t\t\t\t\t\n\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/es\/doge-fda-lease-cancellations\/\" class=\"button  is-link is-small mb-0\">\n\t\t\t\t\t\t\tLeer m\u00e1s\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"eneko_tags_cat\"><h6 class=\"entry-category is-xsmall\"><a href=\"https:\/\/regask.com\/es\/category\/region\/north-america\/united-states-regulations\/\" class=\"category-united-states-regulations\">Estados Unidos<\/a> <a href=\"https:\/\/regask.com\/es\/category\/news\/\" class=\"category-news\">Noticias regulatorias<\/a><\/h6><\/div>\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div><div class=\"col post-item\" >\n\t\t\t<div class=\"col-inner\">\n\t\t\t\t<div class=\"box box-normal box-text-bottom box-blog-post has-hover\">\n            \t\t\t\t\t<div class=\"box-image\" >\n  \t\t\t\t\t\t<div class=\"image-cover\" style=\"padding-top:56%;\">\n\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/es\/france-ansm-ce-mark-exemption\/\" class=\"plain\" aria-label=\"ANSM (Francia) aclara el proceso de exenci\u00f3n de la marca CE para M...\">\n\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"576\" src=\"https:\/\/regask.com\/wp-content\/uploads\/2025\/02\/ansm-france-clarifies-ce-mark-exemption-process-medical-devices.png\" class=\"attachment-medium_large size-medium_large wp-post-image\" alt=\"Ansm France aclara el proceso de exenci\u00f3n de la marca CE para dispositivos m\u00e9dicos\" srcset=\"https:\/\/regask.com\/wp-content\/uploads\/2025\/02\/ansm-france-clarifies-ce-mark-exemption-process-medical-devices.png 800w, https:\/\/regask.com\/wp-content\/uploads\/2025\/02\/ansm-france-clarifies-ce-mark-exemption-process-medical-devices-330x248.png 330w, https:\/\/regask.com\/wp-content\/uploads\/2025\/02\/ansm-france-clarifies-ce-mark-exemption-process-medical-devices-16x12.png 16w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" \/>\t\t\t\t\t\t\t<\/a>\n  \t\t\t\t\t\t\t  \t\t\t\t\t\t\t  \t\t\t\t\t\t<\/div>\n  \t\t\t\t\t\t  \t\t\t\t\t<\/div>\n          \t\t\t\t\t<div class=\"box-text text-left\" style=\"padding:20px 0px 0px 0px;\">\n\t\t\t\t\t<div class=\"box-text-inner blog-post-inner\">\n\n\t\t\t\t\t\n\t\t\t\t\t<div class=\"post-meta is-small op-8\">26 de febrero de 2025 -  <a style=\"color:#453AAB!important;\" href=\"https:\/\/regask.com\/es\/category\/news\/\">Noticias regulatorias<\/a><\/div>\t\t\t\t\t\n\n\t\t\t\t\t<div class=\"is-divider\"><\/div>\n\n\t\t\t\t\t<h5 class=\"post-title is-large\">\n\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/es\/france-ansm-ce-mark-exemption\/\" class=\"plain\">ANSM (Francia) aclara el proceso de exenci\u00f3n de la marca CE para M...<\/a>\n\t\t\t\t\t<\/h5>\n\t\t\t\t\t\n\t\t\t\t\t<div class=\"min-height-excerpt\">\n\t\t\t\t\tEl 27 de enero de 2025, la Agencia Nacional de Seguridad de Medicamentos y Productos Sanitarios (ANSM) de Francia emiti\u00f3 una actualizaci\u00f3n clave sobre el proces\u2026 <br \/>\t\t\t\t\t<\/div>\n\n\t\t\t\t\t\n\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/es\/france-ansm-ce-mark-exemption\/\" class=\"button  is-link is-small mb-0\">\n\t\t\t\t\t\t\tLeer m\u00e1s\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"eneko_tags_cat\"><h6 class=\"entry-category is-xsmall\"><a href=\"https:\/\/regask.com\/es\/category\/region\/europe\/france-regulations\/\" class=\"category-france-regulations\">Francia<\/a> <a href=\"https:\/\/regask.com\/es\/category\/news\/medical-devices-insights\/\" class=\"category-medical-devices-insights\">Dispositivos m\u00e9dicos<\/a><\/h6><\/div>\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div><div class=\"col post-item\" >\n\t\t\t<div class=\"col-inner\">\n\t\t\t\t<div class=\"box box-normal box-text-bottom box-blog-post has-hover\">\n            \t\t\t\t\t<div class=\"box-image\" >\n  \t\t\t\t\t\t<div class=\"image-cover\" style=\"padding-top:56%;\">\n\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/es\/us-fda-ai-drug-regulation-guidance\/\" class=\"plain\" aria-label=\"La FDA de EE. UU. anuncia un borrador de gu\u00eda sobre el uso de IA en...\">\n\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"576\" src=\"https:\/\/regask.com\/wp-content\/uploads\/2025\/01\/us-fda-announces-draft-guidance-ai-use-regulatory-decision-making-drug-biological-products.png\" class=\"attachment-medium_large size-medium_large wp-post-image\" alt=\"La FDA de EE. UU. anuncia un borrador de gu\u00eda sobre la toma de decisiones regulatorias para el uso de IA en productos biol\u00f3gicos\" srcset=\"https:\/\/regask.com\/wp-content\/uploads\/2025\/01\/us-fda-announces-draft-guidance-ai-use-regulatory-decision-making-drug-biological-products.png 800w, https:\/\/regask.com\/wp-content\/uploads\/2025\/01\/us-fda-announces-draft-guidance-ai-use-regulatory-decision-making-drug-biological-products-330x248.png 330w, https:\/\/regask.com\/wp-content\/uploads\/2025\/01\/us-fda-announces-draft-guidance-ai-use-regulatory-decision-making-drug-biological-products-16x12.png 16w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" \/>\t\t\t\t\t\t\t<\/a>\n  \t\t\t\t\t\t\t  \t\t\t\t\t\t\t  \t\t\t\t\t\t<\/div>\n  \t\t\t\t\t\t  \t\t\t\t\t<\/div>\n          \t\t\t\t\t<div class=\"box-text text-left\" style=\"padding:20px 0px 0px 0px;\">\n\t\t\t\t\t<div class=\"box-text-inner blog-post-inner\">\n\n\t\t\t\t\t\n\t\t\t\t\t<div class=\"post-meta is-small op-8\">22 de enero de 2025 -  <a style=\"color:#453AAB!important;\" href=\"https:\/\/regask.com\/es\/category\/news\/\">Noticias regulatorias<\/a><\/div>\t\t\t\t\t\n\n\t\t\t\t\t<div class=\"is-divider\"><\/div>\n\n\t\t\t\t\t<h5 class=\"post-title is-large\">\n\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/es\/us-fda-ai-drug-regulation-guidance\/\" class=\"plain\">La FDA de EE. UU. anuncia un borrador de gu\u00eda sobre el uso de IA en...<\/a>\n\t\t\t\t\t<\/h5>\n\t\t\t\t\t\n\t\t\t\t\t<div class=\"min-height-excerpt\">\n\t\t\t\t\tEl 6 de enero de 2025, la Administraci\u00f3n de Alimentos y Medicamentos de los Estados Unidos (FDA) anunci\u00f3 la publicaci\u00f3n de un borrador de gu\u00eda titulado \u201cConsideraciones para la\u2026 <br \/>\t\t\t\t\t<\/div>\n\n\t\t\t\t\t\n\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/es\/us-fda-ai-drug-regulation-guidance\/\" class=\"button  is-link is-small mb-0\">\n\t\t\t\t\t\t\tLeer m\u00e1s\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"eneko_tags_cat\"><h6 class=\"entry-category is-xsmall\"><a href=\"https:\/\/regask.com\/es\/category\/region\/north-america\/united-states-regulations\/\" class=\"category-united-states-regulations\">Estados Unidos<\/a> <a href=\"https:\/\/regask.com\/es\/category\/news\/pharma-biotech-latest-insights\/\" class=\"category-pharma-biotech-latest-insights\">Farmacia y biotecnolog\u00eda<\/a><\/h6><\/div>\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div><div class=\"col post-item\" >\n\t\t\t<div class=\"col-inner\">\n\t\t\t\t<div class=\"box box-normal box-text-bottom box-blog-post has-hover\">\n            \t\t\t\t\t<div class=\"box-image\" >\n  \t\t\t\t\t\t<div class=\"image-cover\" style=\"padding-top:56%;\">\n\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/es\/us-fda-pediatric-drug-meeting\/\" class=\"plain\" aria-label=\"La FDA de EE. UU. anuncia una reuni\u00f3n p\u00fablica sobre legislaci\u00f3n pedi\u00e1trica\u2026\">\n\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"576\" src=\"https:\/\/regask.com\/wp-content\/uploads\/2025\/01\/us-fda-announces-public-meeting-paediatric-legislation-impact-drug-biologic-development-children.png\" class=\"attachment-medium_large size-medium_large wp-post-image\" alt=\"La FDA de EE. UU. anuncia una reuni\u00f3n p\u00fablica sobre el impacto de la legislaci\u00f3n pedi\u00e1trica en el desarrollo de medicamentos biol\u00f3gicos para ni\u00f1os\" srcset=\"https:\/\/regask.com\/wp-content\/uploads\/2025\/01\/us-fda-announces-public-meeting-paediatric-legislation-impact-drug-biologic-development-children.png 800w, https:\/\/regask.com\/wp-content\/uploads\/2025\/01\/us-fda-announces-public-meeting-paediatric-legislation-impact-drug-biologic-development-children-330x248.png 330w, https:\/\/regask.com\/wp-content\/uploads\/2025\/01\/us-fda-announces-public-meeting-paediatric-legislation-impact-drug-biologic-development-children-16x12.png 16w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" \/>\t\t\t\t\t\t\t<\/a>\n  \t\t\t\t\t\t\t  \t\t\t\t\t\t\t  \t\t\t\t\t\t<\/div>\n  \t\t\t\t\t\t  \t\t\t\t\t<\/div>\n          \t\t\t\t\t<div class=\"box-text text-left\" style=\"padding:20px 0px 0px 0px;\">\n\t\t\t\t\t<div class=\"box-text-inner blog-post-inner\">\n\n\t\t\t\t\t\n\t\t\t\t\t<div class=\"post-meta is-small op-8\">8 de enero de 2025 -  <a style=\"color:#453AAB!important;\" href=\"https:\/\/regask.com\/es\/category\/news\/\">Noticias regulatorias<\/a><\/div>\t\t\t\t\t\n\n\t\t\t\t\t<div class=\"is-divider\"><\/div>\n\n\t\t\t\t\t<h5 class=\"post-title is-large\">\n\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/es\/us-fda-pediatric-drug-meeting\/\" class=\"plain\">La FDA de EE. UU. anuncia una reuni\u00f3n p\u00fablica sobre legislaci\u00f3n pedi\u00e1trica\u2026<\/a>\n\t\t\t\t\t<\/h5>\n\t\t\t\t\t\n\t\t\t\t\t<div class=\"min-height-excerpt\">\n\t\t\t\t\tLa Administraci\u00f3n de Alimentos y Medicamentos (FDA) ha programado una reuni\u00f3n p\u00fablica titulada \u201cReuni\u00f3n de partes interesadas: Implementaci\u00f3n de las mejores pr\u00e1cticas farmac\u00e9uticas\u201d\u2026 <br \/>\t\t\t\t\t<\/div>\n\n\t\t\t\t\t\n\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/es\/us-fda-pediatric-drug-meeting\/\" class=\"button  is-link is-small mb-0\">\n\t\t\t\t\t\t\tLeer m\u00e1s\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"eneko_tags_cat\"><h6 class=\"entry-category is-xsmall\"><a href=\"https:\/\/regask.com\/es\/category\/region\/north-america\/united-states-regulations\/\" class=\"category-united-states-regulations\">Estados Unidos<\/a> <a href=\"https:\/\/regask.com\/es\/category\/news\/pharma-biotech-latest-insights\/\" class=\"category-pharma-biotech-latest-insights\">Farmacia y biotecnolog\u00eda<\/a><\/h6><\/div>\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div><div class=\"col post-item\" >\n\t\t\t<div class=\"col-inner\">\n\t\t\t\t<div class=\"box box-normal box-text-bottom box-blog-post has-hover\">\n            \t\t\t\t\t<div class=\"box-image\" >\n  \t\t\t\t\t\t<div class=\"image-cover\" style=\"padding-top:56%;\">\n\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/es\/us-fda-real-world-evidence-center\/\" class=\"plain\" aria-label=\"La FDA (EE. UU.) establece un nuevo centro para la evidencia del mundo real\u2026\">\n\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"576\" src=\"https:\/\/regask.com\/wp-content\/uploads\/2024\/12\/fda-usa-establishes-new-center-real-world-evidence-innovation-enhance-drug-safety-efficacy-monitoring.png\" class=\"attachment-medium_large size-medium_large wp-post-image\" alt=\"La FDA de Estados Unidos crea un nuevo centro de pruebas del mundo real para mejorar la innovaci\u00f3n, la seguridad y la eficacia de los medicamentos\" srcset=\"https:\/\/regask.com\/wp-content\/uploads\/2024\/12\/fda-usa-establishes-new-center-real-world-evidence-innovation-enhance-drug-safety-efficacy-monitoring.png 800w, https:\/\/regask.com\/wp-content\/uploads\/2024\/12\/fda-usa-establishes-new-center-real-world-evidence-innovation-enhance-drug-safety-efficacy-monitoring-330x248.png 330w, https:\/\/regask.com\/wp-content\/uploads\/2024\/12\/fda-usa-establishes-new-center-real-world-evidence-innovation-enhance-drug-safety-efficacy-monitoring-16x12.png 16w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" \/>\t\t\t\t\t\t\t<\/a>\n  \t\t\t\t\t\t\t  \t\t\t\t\t\t\t  \t\t\t\t\t\t<\/div>\n  \t\t\t\t\t\t  \t\t\t\t\t<\/div>\n          \t\t\t\t\t<div class=\"box-text text-left\" style=\"padding:20px 0px 0px 0px;\">\n\t\t\t\t\t<div class=\"box-text-inner blog-post-inner\">\n\n\t\t\t\t\t\n\t\t\t\t\t<div class=\"post-meta is-small op-8\">20 de diciembre de 2024 -  <a style=\"color:#453AAB!important;\" href=\"https:\/\/regask.com\/es\/category\/news\/\">Noticias regulatorias<\/a><\/div>\t\t\t\t\t\n\n\t\t\t\t\t<div class=\"is-divider\"><\/div>\n\n\t\t\t\t\t<h5 class=\"post-title is-large\">\n\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/es\/us-fda-real-world-evidence-center\/\" class=\"plain\">La FDA (EE. UU.) establece un nuevo centro para la evidencia del mundo real\u2026<\/a>\n\t\t\t\t\t<\/h5>\n\t\t\t\t\t\n\t\t\t\t\t<div class=\"min-height-excerpt\">\n\t\t\t\t\tEl 12 de diciembre de 2024, la Administraci\u00f3n de Alimentos y Medicamentos de Estados Unidos (FDA) anunci\u00f3 la creaci\u00f3n del Centro de Evidencia e Innovaci\u00f3n del Mundo Real\u2026 <br \/>\t\t\t\t\t<\/div>\n\n\t\t\t\t\t\n\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/es\/us-fda-real-world-evidence-center\/\" class=\"button  is-link is-small mb-0\">\n\t\t\t\t\t\t\tLeer m\u00e1s\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"eneko_tags_cat\"><h6 class=\"entry-category is-xsmall\"><a href=\"https:\/\/regask.com\/es\/category\/region\/north-america\/united-states-regulations\/\" class=\"category-united-states-regulations\">Estados Unidos<\/a> <a href=\"https:\/\/regask.com\/es\/category\/news\/pharma-biotech-latest-insights\/\" class=\"category-pharma-biotech-latest-insights\">Farmacia y biotecnolog\u00eda<\/a><\/h6><\/div>\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div><div class=\"col post-item\" >\n\t\t\t<div class=\"col-inner\">\n\t\t\t\t<div class=\"box box-normal box-text-bottom box-blog-post has-hover\">\n            \t\t\t\t\t<div class=\"box-image\" >\n  \t\t\t\t\t\t<div class=\"image-cover\" style=\"padding-top:56%;\">\n\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/es\/portuguese-industry-us-alcohol-labels\/\" class=\"plain\" aria-label=\"La industria portuguesa se opone a la propuesta estadounidense de\u2026\">\n\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"576\" src=\"https:\/\/regask.com\/wp-content\/uploads\/2025\/01\/portuguese-industry-opposes-us-proposal-cancer-warnings-alcohol-labels.png\" class=\"attachment-medium_large size-medium_large wp-post-image\" alt=\"La industria portuguesa se opone a la propuesta estadounidense de etiquetar las bebidas alcoh\u00f3licas con advertencias sobre el c\u00e1ncer\" srcset=\"https:\/\/regask.com\/wp-content\/uploads\/2025\/01\/portuguese-industry-opposes-us-proposal-cancer-warnings-alcohol-labels.png 800w, https:\/\/regask.com\/wp-content\/uploads\/2025\/01\/portuguese-industry-opposes-us-proposal-cancer-warnings-alcohol-labels-330x248.png 330w, https:\/\/regask.com\/wp-content\/uploads\/2025\/01\/portuguese-industry-opposes-us-proposal-cancer-warnings-alcohol-labels-16x12.png 16w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" \/>\t\t\t\t\t\t\t<\/a>\n  \t\t\t\t\t\t\t  \t\t\t\t\t\t\t  \t\t\t\t\t\t<\/div>\n  \t\t\t\t\t\t  \t\t\t\t\t<\/div>\n          \t\t\t\t\t<div class=\"box-text text-left\" style=\"padding:20px 0px 0px 0px;\">\n\t\t\t\t\t<div class=\"box-text-inner blog-post-inner\">\n\n\t\t\t\t\t\n\t\t\t\t\t<div class=\"post-meta is-small op-8\">28 de enero de 2025 -  <a style=\"color:#453AAB!important;\" href=\"https:\/\/regask.com\/es\/category\/news\/\">Noticias regulatorias<\/a><\/div>\t\t\t\t\t\n\n\t\t\t\t\t<div class=\"is-divider\"><\/div>\n\n\t\t\t\t\t<h5 class=\"post-title is-large\">\n\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/es\/portuguese-industry-us-alcohol-labels\/\" class=\"plain\">La industria portuguesa se opone a la propuesta estadounidense de\u2026<\/a>\n\t\t\t\t\t<\/h5>\n\t\t\t\t\t\n\t\t\t\t\t<div class=\"min-height-excerpt\">\n\t\t\t\t\tLa Autoridad de Salud de los Estados Unidos est\u00e1 considerando la introducci\u00f3n de etiquetas de advertencia obligatorias sobre c\u00e1ncer en las bebidas alcoh\u00f3licas, una medida similar\u2026 <br \/>\t\t\t\t\t<\/div>\n\n\t\t\t\t\t\n\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/es\/portuguese-industry-us-alcohol-labels\/\" class=\"button  is-link is-small mb-0\">\n\t\t\t\t\t\t\tLeer m\u00e1s\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"eneko_tags_cat\"><h6 class=\"entry-category is-xsmall\"><a href=\"https:\/\/regask.com\/es\/category\/news\/pharma-biotech-latest-insights\/\" class=\"category-pharma-biotech-latest-insights\">Farmacia y biotecnolog\u00eda<\/a> <a href=\"https:\/\/regask.com\/es\/category\/region\/europe\/portugal-regulations\/\" class=\"category-portugal-regulations\">Portugal<\/a><\/h6><\/div>\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div><\/div>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1418442477 > .col-inner {\n  margin: 0px 0px 80px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n<\/div>\n\t\t<\/div>\n\n\t\t\n<style>\n#section_71050757 {\n  padding-top: 0px;\n  padding-bottom: 0px;\n}\n<\/style>\n\t<\/section>","protected":false},"excerpt":{"rendered":"","protected":false},"author":32,"featured_media":8585,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"page-blank.php","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-8584","page","type-page","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.8 (Yoast SEO v27.9) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>RegASK to sponsor Pharma Japan 2025<\/title>\n<meta name=\"description\" content=\"Join RegASK at Pharma Japan 2025 in The Westin, Tokyo as we showcase our AI-driven regulatory intelligence helping pharmaceutical companies navigate compliance, innovation, and patient-centric transformation in Japan\u2019s evolving pharma landscape.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/regask.com\/es\/farmaceutica-japon-2025\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharma Japan 2025\" \/>\n<meta property=\"og:description\" content=\"Join RegASK at Pharma Japan 2025 in The Westin, Tokyo as we showcase our AI-driven regulatory intelligence helping pharmaceutical companies navigate compliance, innovation, and patient-centric transformation in Japan\u2019s evolving pharma landscape.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/regask.com\/es\/farmaceutica-japon-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"RegASK\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/\" \/>\n<meta property=\"article:modified_time\" content=\"2025-09-04T09:05:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/regask.com\/wp-content\/uploads\/2025\/08\/RegASK-Pharma-Japan-2025_Landing-Page.png\" \/>\n\t<meta property=\"og:image:width\" content=\"720\" \/>\n\t<meta property=\"og:image:height\" content=\"720\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"4 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/regask.com\\\/pharma-japan-2025\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/pharma-japan-2025\\\/\",\"name\":\"RegASK to sponsor Pharma Japan 2025\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/pharma-japan-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/pharma-japan-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/RegASK-Pharma-Japan-2025_Landing-Page.png\",\"datePublished\":\"2025-08-19T06:56:00+00:00\",\"dateModified\":\"2025-09-04T09:05:39+00:00\",\"description\":\"Join RegASK at Pharma Japan 2025 in The Westin, Tokyo as we showcase our AI-driven regulatory intelligence helping pharmaceutical companies navigate compliance, innovation, and patient-centric transformation in Japan\u2019s evolving pharma landscape.\",\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/regask.com\\\/pharma-japan-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/regask.com\\\/pharma-japan-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/RegASK-Pharma-Japan-2025_Landing-Page.png\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/RegASK-Pharma-Japan-2025_Landing-Page.png\",\"width\":720,\"height\":720,\"caption\":\"Regask Pharma Japan 2025 Landing Page\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/regask.com\\\/#website\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"name\":\"RegASK\",\"description\":\"The Regulatory AI Operating System for High-Performing Teams\",\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/regask.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"RegASK patrocinar\u00e1 Pharma Japan 2025","description":"\u00danase a RegASK en Pharma Japan 2025 en The Westin, Tokio, mientras mostramos nuestra inteligencia regulatoria impulsada por IA que ayuda a las compa\u00f1\u00edas farmac\u00e9uticas a navegar el cumplimiento, la innovaci\u00f3n y la transformaci\u00f3n centrada en el paciente en el cambiante panorama farmac\u00e9utico de Jap\u00f3n.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/regask.com\/es\/farmaceutica-japon-2025\/","og_locale":"es_ES","og_type":"article","og_title":"Pharma Japan 2025","og_description":"Join RegASK at Pharma Japan 2025 in The Westin, Tokyo as we showcase our AI-driven regulatory intelligence helping pharmaceutical companies navigate compliance, innovation, and patient-centric transformation in Japan\u2019s evolving pharma landscape.","og_url":"https:\/\/regask.com\/es\/farmaceutica-japon-2025\/","og_site_name":"RegASK","article_publisher":"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","article_modified_time":"2025-09-04T09:05:39+00:00","og_image":[{"width":720,"height":720,"url":"https:\/\/regask.com\/wp-content\/uploads\/2025\/08\/RegASK-Pharma-Japan-2025_Landing-Page.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_site":"@ASKRegASK","twitter_misc":{"Est. reading time":"4 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/regask.com\/pharma-japan-2025\/","url":"https:\/\/regask.com\/pharma-japan-2025\/","name":"RegASK patrocinar\u00e1 Pharma Japan 2025","isPartOf":{"@id":"https:\/\/regask.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/regask.com\/pharma-japan-2025\/#primaryimage"},"image":{"@id":"https:\/\/regask.com\/pharma-japan-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2025\/08\/RegASK-Pharma-Japan-2025_Landing-Page.png","datePublished":"2025-08-19T06:56:00+00:00","dateModified":"2025-09-04T09:05:39+00:00","description":"\u00danase a RegASK en Pharma Japan 2025 en The Westin, Tokio, mientras mostramos nuestra inteligencia regulatoria impulsada por IA que ayuda a las compa\u00f1\u00edas farmac\u00e9uticas a navegar el cumplimiento, la innovaci\u00f3n y la transformaci\u00f3n centrada en el paciente en el cambiante panorama farmac\u00e9utico de Jap\u00f3n.","inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/regask.com\/pharma-japan-2025\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/regask.com\/pharma-japan-2025\/#primaryimage","url":"https:\/\/regask.com\/wp-content\/uploads\/2025\/08\/RegASK-Pharma-Japan-2025_Landing-Page.png","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2025\/08\/RegASK-Pharma-Japan-2025_Landing-Page.png","width":720,"height":720,"caption":"Regask Pharma Japan 2025 Landing Page"},{"@type":"WebSite","@id":"https:\/\/regask.com\/#website","url":"https:\/\/regask.com\/","name":"RegASK","description":"El sistema operativo de IA regulatoria para equipos de alto rendimiento","publisher":{"@id":"https:\/\/regask.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/regask.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"}]}},"_links":{"self":[{"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/pages\/8584","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/users\/32"}],"replies":[{"embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/comments?post=8584"}],"version-history":[{"count":0,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/pages\/8584\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/media\/8585"}],"wp:attachment":[{"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/media?parent=8584"}],"curies":[{"name":"Gracias","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}